Topiramate Tablet, Film Coated
Product Images NDC 80425-0214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Description (Description)
Chemical structure of Topiramate, the active ingredient shown in the image. The diagram depicts the molecular framework including groups such as CH3, CH2OSO2NH2, and other characteristic rings and bonds of Topiramate.*
FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
A line graph comparing cumulative rates for time to first seizure over 500 days between two doses of Topiramate, 50 mg/day (N=234) and 400 mg/day (N=236). The x-axis represents time in days, and the y-axis shows cumulative rates. Statistical significance is indicated with p = 0.0002.*
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
A bar chart comparing change from baseline to double-blind phase in average monthly migraine period rate across placebo and topiramate doses of 50 mg/day, 100 mg/day, and 200 mg/day in two studies. Bars represent Study 1 and Study 2 with standard error bars, showing greater reduction at higher topiramate doses. Statistical significance is noted with asterisks for differences versus placebo.*
FDA Label Image

Label 1 (Topiramate 80425 0214 02)

Label 1 (Topiramate 80425 0214 02)
Topiramate 50 mg film-coated tablet label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20-25°C), a lot number placeholder, and expiration date of 9/30/2024. It references comparison to Topamax and displays product NDC 80425-0214-02.*
FDA Label Image

Image (Image)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.